Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
SYNTHELIS logo — Cell-free systems expert ! The futures of protein ! Best ch...

SYNTHELIS

Cell-free systems expert ! The futures of protein ! Best chance for your protein projects !

Founded 2011 France France 10 employees Venture round Total: $610.00K Biotechnology, Health Care +2

General Information

Company Name SYNTHELIS
Founded Year 2011
Location France France
Employees 10
Industries Biotechnology, Health Care, Manufacturing +1
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with SYNTHELIS. To contact SYNTHELIS, visit synthelis.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does SYNTHELIS compare?

A PDF of SYNTHELIS and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting SYNTHELIS soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About SYNTHELIS

SYNTHELIS is a French biotech company based in Grenoble, at the heart of the French Alps, pioneering in Cell-Free systems. Established in 2011, it has become a benchmark in Europe with its proprietary cell-free expression technology and is now positioned to compete with US leaders in the field. The company addresses the pressing need to efficiently produce diverse proteins in research and anticipates its growing significance in various industries in the future. The consistent growth in cell-free expression expertise aligns with the unfolding industrial revolution, and SYNTHELIS is dedicated to advancing its research to contribute to the emergence of synthetic biology. The company secured a €610.00K Venture Round investment on 21 January 2014 from Alpes Developpement Durable Investissement, Rhone-Alpes Creation, Sud Rhone-Alpes Capital, and Viadeo. With its strong expertise and strategic vision, SYNTHELIS presents a promising opportunity for venture capitalists in the dynamic biotech landscape.

Business keywords: Cell-Free Systems, Protein Expression, Membrane Proteins, Proteoliposomes, Detergent Format, Pharmaceutical Services, Biotech, Vaccine Development, Screening Technologies, Antibody Development, In Vitro Diagnostics, Structural Biology, Protein Purification, Therapeutic Proteins, Synthetic Biology

Services & Products

Expression of Proteins in Cell-Free Systems
Expression of Proteins in E. coli
Bioluminescence Products and Services

Target Customers

Biopharmaceutical Industry Biotechnology Companies Diagnostic Laboratories Academic Research Institutions

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round €610.00K 4
Alpes Developpement Durable Investissement Rhone-Alpes Creation Sud Rhone-Alpes Capital
Alpes Developpement Durable Investissement, Rhone-Alpes Creation +2
21 Jan 2014

SYNTHELIS Alternatives & Competitors

View All Alternatives
SYNTHELIS vs
Dima Biotechnology
Dima Biotechnology United States

Recombinant monoclonal antibodies and membrane proteins for drug discovery.

Angel
6 employees
Biotechnology, Health Care
SYNTHELIS vs
神州细胞工程有限公司
神州细胞工程有限公司

Pioneering accessible and affordable biological medicines through advanced protein and antibody tech...

Series A
91 employees
Biotechnology, Health Care
SYNTHELIS vs
MSM Protein Technologies, Inc.
MSM Protein Technologies, Inc.

Pioneering novel methods for precise targeting of challenging therapeutic proteins in drug discovery...

Seed
5 employees
Biotechnology, Health Care
View all alternatives

FAQ About SYNTHELIS

Cell-free systems expert ! The futures of protein ! Best chance for your protein projects !
SYNTHELIS was founded in 2011.
SYNTHELIS is headquartered in France.
SYNTHELIS operates in Biotechnology, Health Care, Manufacturing and Transportation. Its work centres on Cell-Free Systems, Protein Expression, Membrane Proteins and Proteoliposomes. Its customers include Biopharmaceutical Industry, Biotechnology Companies and Diagnostic Laboratories.
SYNTHELIS has approximately 10 employees.
SYNTHELIS has completed 1 funding round, raising a total of $610.00K. The latest funding stage is Venture round.
SYNTHELIS offers: Expression of Proteins in Cell-Free Systems, Expression of Proteins in E. coli, Bioluminescence Products and Services.
Top alternatives and competitors to SYNTHELIS include Dima Biotechnology, 神州细胞工程有限公司, MSM Protein Technologies, Inc., Protein Alternatives SL (PROALT), KACTUS. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
SYNTHELIS and Dima Biotechnology are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for SYNTHELIS, https://bouncewatch.com/company/synthelis, updated 11 June 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes